Polaris Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History

Polaris Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$27.7 - $35.48 $454,280 - $581,872	-16,400 Reduced 74.55%	5,600 $163,000
Q4 2023 Feb 07, 2024	SELL	$26.32 - $34.31 $86,856 - $113,223	-3,300 Reduced 13.04%	22,000 $742,000
Q4 2022 Feb 09, 2023	BUY	$38.19 - $57.45 $511,745 - $769,830	13,400 Added 112.61%	25,300 $976,000
Q2 2022 Aug 12, 2022	SELL	$51.49 - $81.64 $1.77 Million - $2.8 Million	-34,320 Reduced 74.25%	11,900 $694,000
Q2 2022 Aug 10, 2022	BUY	$51.49 - $81.64 $1.94 Million - $3.07 Million	37,620 Added 437.44%	46,220 $1.22 Million
Q4 2021 Feb 01, 2022	BUY	$47.97 - $62.21 $412,542 - $535,006	8,600 New	8,600 $517,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.1B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Polaris Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Polaris Capital Management, LLC with notifications on news.